Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Iohexol for Postoperative Chylous Ascites
NCT06820320Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iohexol in chylous ascites (CA), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Feb 2025; status: completed.
02
Drugs
iohexol
03
Conditions
chylous ascites (CA)
Beyond the preview
Go deeper on NCT06820320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06820320.